Devin M Pillis

1PUBLICATIONS
3CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 30, 2019
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites.

Rajeswari Jayavaradhan, Devin M Pillis, Michael Goodman

Pageof 1